Table 2. Characteristics of MET exon 14 deletion (METex14) patients according to tumor types.
Colon | Gastric | ACUP | Lung | |
---|---|---|---|---|
N | 4 | 3 | 1 | 5 |
Age | ||||
Median | 63 | 53 | 49 | |
(range) | 42–87 | 27–67 | 36–60 | |
Gender | ||||
Male | 2 | 2 | 1 | 1 |
Female | 2 | 1 | 0 | 4 |
Smoking history | ||||
Never-smoker | NC | NC | NC | 4 |
Ever-smoker | 1 | |||
Histology | ||||
Adenocarcinoma | 4 | 3 | 1 | 4 |
Squamous cell | 0 | 0 | 0 | 1 |
Large cell neuroendocrine | 0 | 0 | 0 | 0 |
Undifferentiated | 0 | 0 | 0 | 0 |
Tumor differentiation | ||||
Well | 1 | 0 | 0 | 0 |
Moderate | 2 | 0 | 0 | 1 |
Poor | 1 | 3 | 1 | 4 |
MET IHC | ||||
0 | 0 | 0 | 0 | 0 |
1+ | 0 | 0 | 0 | 0 |
2+ | 1 | 0 | 0 | 0 |
3+ | 3 | 3 | 1 | 5 |
Concomitant MET amplification | ||||
Yes | 0 | 1 | 0 | 0 |
No | 4 | 2 | 0 | 5 |
Confirmed by RT-PCR | ||||
Yes | 4 | 3 | 1 | 5 |
No | 0 | 0 | 0 | 0 |
NC, not contributable; wt, wild type.